These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

532 related items for PubMed ID: 19439812

  • 1. Differential effects of in vivo PPAR alpha and gamma activation on fatty acid transport proteins expression and lipid content in rat liver.
    Wierzbicki M, Chabowski A, Zendzian-Piotrowska M, Gorski J.
    J Physiol Pharmacol; 2009 Mar; 60(1):99-106. PubMed ID: 19439812
    [Abstract] [Full Text] [Related]

  • 2. Differential effects of contraction and PPAR agonists on the expression of fatty acid transporters in rat skeletal muscle.
    Benton CR, Koonen DP, Calles-Escandon J, Tandon NN, Glatz JF, Luiken JJ, Heikkila JJ, Bonen A.
    J Physiol; 2006 May 15; 573(Pt 1):199-210. PubMed ID: 16484294
    [Abstract] [Full Text] [Related]

  • 3. Chronic, in vivo, PPARalpha activation prevents lipid overload in rat liver induced by high fat feeding.
    Wierzbicki M, Chabowski A, Zendzian-Piotrowska M, Harasim E, Górski J.
    Adv Med Sci; 2009 May 15; 54(1):59-65. PubMed ID: 19403437
    [Abstract] [Full Text] [Related]

  • 4. PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes.
    Seo YS, Kim JH, Jo NY, Choi KM, Baik SH, Park JJ, Kim JS, Byun KS, Bak YT, Lee CH, Kim A, Yeon JE.
    J Gastroenterol Hepatol; 2008 Jan 15; 23(1):102-9. PubMed ID: 18171348
    [Abstract] [Full Text] [Related]

  • 5. PPARalpha and PPARgamma regulation of liver and adipose proteins in obese and dyslipidemic rodents.
    Lanne B, Dahllöf B, Lindahl C, Ebefors K, Kanmert I, von Bahr H, Miliotis T, Nyström AC, Arnerup G, Paulsons I, Kerb S, Oakes N.
    J Proteome Res; 2006 Aug 15; 5(8):1850-9. PubMed ID: 16889406
    [Abstract] [Full Text] [Related]

  • 6. Peroxisome proliferator-activated receptor alpha activation induces unfavourable changes in fatty acid composition of myocardial phospholipids.
    Baranowski M, Blachnio-Zabielska A, Gorski J.
    J Physiol Pharmacol; 2009 Jun 15; 60(2):13-20. PubMed ID: 19617640
    [Abstract] [Full Text] [Related]

  • 7. Enhancement of insulin signaling through inhibition of tissue lipid accumulation by activation of peroxisome proliferator-activated receptor (PPAR) alpha in obese mice.
    Ide T, Tsunoda M, Mochizuki T, Murakami K.
    Med Sci Monit; 2004 Oct 15; 10(10):BR388-95. PubMed ID: 15448592
    [Abstract] [Full Text] [Related]

  • 8. Importance of PPAR alpha for the effects of growth hormone on hepatic lipid and lipoprotein metabolism.
    Ljungberg A, Lindén D, Améen C, Bergström G, Oscarsson J.
    Growth Horm IGF Res; 2007 Apr 15; 17(2):154-64. PubMed ID: 17307376
    [Abstract] [Full Text] [Related]

  • 9. Effects of cevoglitazar, a dual PPARalpha/gamma agonist, on ectopic fat deposition in fatty Zucker rats.
    Laurent D, Gounarides JS, Gao J, Boettcher BR.
    Diabetes Obes Metab; 2009 Jun 15; 11(6):632-6. PubMed ID: 19175377
    [Abstract] [Full Text] [Related]

  • 10. Fine metabolic regulation in ruminants via nutrient-gene interactions: saturated long-chain fatty acids increase expression of genes involved in lipid metabolism and immune response partly through PPAR-α activation.
    Bionaz M, Thering BJ, Loor JJ.
    Br J Nutr; 2012 Jan 15; 107(2):179-91. PubMed ID: 21729373
    [Abstract] [Full Text] [Related]

  • 11. A role for PPARalpha in the control of SREBP activity and lipid synthesis in the liver.
    Knight BL, Hebbachi A, Hauton D, Brown AM, Wiggins D, Patel DD, Gibbons GF.
    Biochem J; 2005 Jul 15; 389(Pt 2):413-21. PubMed ID: 15777286
    [Abstract] [Full Text] [Related]

  • 12. Investigation of potential mechanisms regulating protein expression of hepatic pyruvate dehydrogenase kinase isoforms 2 and 4 by fatty acids and thyroid hormone.
    Holness MJ, Bulmer K, Smith ND, Sugden MC.
    Biochem J; 2003 Feb 01; 369(Pt 3):687-95. PubMed ID: 12435272
    [Abstract] [Full Text] [Related]

  • 13. Characterization of Madin-Darby bovine kidney cell line for peroxisome proliferator-activated receptors: temporal response and sensitivity to fatty acids.
    Bionaz M, Baumrucker CR, Shirk E, Vanden Heuvel JP, Block E, Varga GA.
    J Dairy Sci; 2008 Jul 01; 91(7):2808-13. PubMed ID: 18565938
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of the peroxisome proliferator-activated receptor-alpha agonists clofibrate and fish oil on hepatic fatty acid metabolism in weaned dairy calves.
    Litherland NB, Bionaz M, Wallace RL, Loor JJ, Drackley JK.
    J Dairy Sci; 2010 Jun 01; 93(6):2404-18. PubMed ID: 20494149
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Differential modulation of PPARalpha and gamma target gene expression in the liver and kidney of rats treated with aspirin.
    Fidaleo M, Berardi E, Sartori C.
    Exp Toxicol Pathol; 2008 Apr 01; 59(6):391-7. PubMed ID: 18222077
    [Abstract] [Full Text] [Related]

  • 18. Metabolic action of peroxisome proliferator-activated receptor gamma agonism in rats with exogenous hypercorticosteronemia.
    Berthiaume M, Laplante M, Tchernof A, Deshaies Y.
    Int J Obes (Lond); 2007 Nov 01; 31(11):1660-70. PubMed ID: 17579631
    [Abstract] [Full Text] [Related]

  • 19. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.
    Touyz RM, Schiffrin EL.
    Vascul Pharmacol; 2006 Jul 01; 45(1):19-28. PubMed ID: 16782410
    [Abstract] [Full Text] [Related]

  • 20. Transcriptional regulation of murine Slc22a1 (Oct1) by peroxisome proliferator agonist receptor-alpha and -gamma.
    Nie W, Sweetser S, Rinella M, Green RM.
    Am J Physiol Gastrointest Liver Physiol; 2005 Feb 01; 288(2):G207-12. PubMed ID: 15458920
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.